U.S. Sen. Baldwin: Celebrates AstraZeneca’s commitment to extend $35 cap to new inhalers

WASHINGTON, D.C. – Today, U.S. Senator Tammy Baldwin (D-WI), a member of the Senate Committee on Health, Education, Labor, and Pensions, celebrated the announcement that AstraZeneca will cap the cost of more of their new inhalers at $35. This announcement comes after Baldwin launched an investigation into the extremely high prices pharmaceutical companies charge for inhalers that 25...